Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
Abbadessa G, Lepore MT, Bruzzaniti S, Piemonte E, Miele G, Signoriello E, Perna F, De Falco C, Lus G, Matarese G, Bonavita S, Galgani M. Abbadessa G, et al. Among authors: bruzzaniti s. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200250. doi: 10.1212/NXI.0000000000200250. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662990 Free PMC article.
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells.
Pagano C, Coppola L, Navarra G, Avilia G, Bruzzaniti S, Piemonte E, Galgani M, Della Monica R, Chiariotti L, Cuomo M, Buonaiuto M, Torelli G, Caiazzo P, Laezza C, Bifulco M. Pagano C, et al. Among authors: bruzzaniti s. Cancers (Basel). 2022 Dec 8;14(24):6044. doi: 10.3390/cancers14246044. Cancers (Basel). 2022. PMID: 36551529 Free PMC article.
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
Strollo R, Vinci C, Man YKS, Bruzzaniti S, Piemonte E, Alhamar G, Briganti SI, Malandrucco I, Tramontana F, Fanali C, Garnett J, Buccafusca R, Guyer P, Mamula M, James EA, Pozzilli P, Ludvigsson J, Winyard PG, Galgani M, Nissim A. Strollo R, et al. Among authors: bruzzaniti s. Diabetologia. 2023 Jan;66(1):132-146. doi: 10.1007/s00125-022-05812-4. Epub 2022 Oct 7. Diabetologia. 2023. PMID: 36207582 Free PMC article.
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.
Bruzzaniti S, Piemonte E, Mozzillo E, Bruzzese D, Lepore MT, Carbone F, de Candia P, Strollo R, Porcellini A, Marigliano M, Maffeis C, Bifulco M, Ludvigsson J, Franzese A, Matarese G, Galgani M. Bruzzaniti S, et al. Diabetologia. 2022 Aug;65(8):1390-1397. doi: 10.1007/s00125-022-05724-3. Epub 2022 May 25. Diabetologia. 2022. PMID: 35610521
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Stampanoni Bassi M, Gilio L, Buttari F, Procaccini C, Colamatteo A, Bullitta S, Guadalupi L, Caioli S, Vanni V, Balletta S, Sanna K, Bruno A, Dolcetti E, Furlan R, Finardi A, Licursi V, Drulovic J, Pekmezovic T, Fusco C, Bruzzaniti S, Hornstein E, Uccelli A, Salvetti M, Matarese G, Centonze D, Mandolesi G. De Vito F, et al. Among authors: bruzzaniti s. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12765. doi: 10.1111/nan.12765. Epub 2021 Oct 6. Neuropathol Appl Neurobiol. 2022. PMID: 34490928 Free PMC article.
Metabolomics, Lipidomics, and Immunometabolism.
Carbone F, Bruzzaniti S, Fusco C, Colamatteo A, Micillo T, De Candia P, Bonacina F, Norata GD, Matarese G. Carbone F, et al. Among authors: bruzzaniti s. Methods Mol Biol. 2021;2285:319-328. doi: 10.1007/978-1-0716-1311-5_24. Methods Mol Biol. 2021. PMID: 33928562
27 results